These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Practice parameters for the management of colon cancer. Chang GJ; Kaiser AM; Mills S; Rafferty JF; Buie WD; Dis Colon Rectum; 2012 Aug; 55(8):831-43. PubMed ID: 22810468 [No Abstract] [Full Text] [Related]
6. The prognosis of colon cancer is dependent on accurate staging. Temple LK J Surg Oncol; 2010 Jul; 102(1):1-2. PubMed ID: 20578171 [No Abstract] [Full Text] [Related]
7. Clinically important aspects of lymph node assessment in colon cancer. Wright FC; Law CH; Berry S; Smith AJ J Surg Oncol; 2009 Mar; 99(4):248-55. PubMed ID: 19235179 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of eIF3e is correlated with colon tumor development and poor prognosis. Li Z; Lin S; Jiang T; Wang J; Lu H; Tang H; Teng M; Fan J Int J Clin Exp Pathol; 2014; 7(10):6462-74. PubMed ID: 25400724 [TBL] [Abstract][Full Text] [Related]
10. [Expression of molecular markers detected by immunohistochemistry and risk of lymph node metastasis in stage T1 and T2 colorecrectal cancers]. Wang FL; Wan DS; Lu ZH; Fang YJ; Li LR; Chen G; Wu XJ; Ding PR; Kong LH; Lin JZ; Pan ZZ Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):277-81. PubMed ID: 23985256 [TBL] [Abstract][Full Text] [Related]
11. Lymph node evaluation in colon cancer: assessing the link between quality indicators and quality. Wong SL JAMA; 2011 Sep; 306(10):1139-41. PubMed ID: 21917585 [No Abstract] [Full Text] [Related]
13. The prognostic significance of lymph node size in node-positive colon cancer. Schrembs P; Martin B; Anthuber M; Schenkirsch G; Märkl B PLoS One; 2018; 13(8):e0201072. PubMed ID: 30096142 [TBL] [Abstract][Full Text] [Related]
14. Lymph node ratio as a quality and prognostic indicator in stage III colon cancer. Chen SL; Steele SR; Eberhardt J; Zhu K; Bilchik A; Stojadinovic A Ann Surg; 2011 Jan; 253(1):82-7. PubMed ID: 21135690 [TBL] [Abstract][Full Text] [Related]
15. Up-regulation of Tim-3 is associated with poor prognosis of patients with colon cancer. Zhou E; Huang Q; Wang J; Fang C; Yang L; Zhu M; Chen J; Chen L; Dong M Int J Clin Exp Pathol; 2015; 8(7):8018-27. PubMed ID: 26339368 [TBL] [Abstract][Full Text] [Related]
16. [Effect of lymph node dissection on prognosis of colon carcinoma]. Klupp J; Engels S; Junginger T Zentralbl Chir; 1995; 120(10):821-5. PubMed ID: 7502600 [TBL] [Abstract][Full Text] [Related]
17. Colon cancer screening in a large, multispecialty group practice. Hatfield AK; Bozinovich MA; Steiner JA; Alster JM; Imrey PB Prog Clin Biol Res; 1984; 156():283-94. PubMed ID: 6473437 [No Abstract] [Full Text] [Related]
18. Lymphatic metastasis and nm23H1 genetic instability in Chinese colon cancer patients. Su ZH; Li JC World J Gastroenterol; 2004 Oct; 10(19):2800-4. PubMed ID: 15334673 [TBL] [Abstract][Full Text] [Related]
19. KRAS mutation associated with CD44/CD166 immunoexpression as predictors of worse outcome in metastatic colon cancer. Ribeiro KB; da Silva Zanetti J; Ribeiro-Silva A; Rapatoni L; de Oliveira HF; da Cunha Tirapelli DP; Garcia SB; Feres O; da Rocha JJ; Peria FM Cancer Biomark; 2016 Mar; 16(4):513-21. PubMed ID: 27062566 [TBL] [Abstract][Full Text] [Related]
20. Last decade brought new guidelines, detection methods for colon cancer screening. Zielinski SL J Natl Cancer Inst; 2004 Nov; 96(21):1575. PubMed ID: 15523085 [No Abstract] [Full Text] [Related] [Next] [New Search]